{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T05:28:38Z","timestamp":1682054918558},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,1,1]]},"DOI":"10.2169\/internalmedicine.9467-22","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T22:09:23Z","timestamp":1653948563000},"page":"135-138","source":"Crossref","is-referenced-by-count":1,"title":["Hemodialysis Patient with Streptococcal Toxic Shock Syndrome and Penile Necrosis"],"prefix":"10.2169","volume":"62","author":[{"given":"Kunihiro","family":"Nakai","sequence":"first","affiliation":[{"name":"Department of Nephrology, Omihachiman Community Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Mihara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Omihachiman Community Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kado","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Omihachiman Community Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Omihachiman Community Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguru","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Omihachiman Community Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 14: 2-11, 1992.","DOI":"10.1093\/clinids\/14.1.2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Karpman E, Das S, Kurzrock EA. Penile calciphylaxis: analysis of risk factors and mortality. J Urol 169: 2206-2209, 2003.","DOI":"10.1097\/01.ju.0000064334.85656.a1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 32: 384-391, 1998.","DOI":"10.1053\/ajkd.1998.v32.pm9740153"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med 378: 1704-1714, 2018.","DOI":"10.1056\/NEJMra1505292"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hayashi M. Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol 17: 498-503, 2013.","DOI":"10.1007\/s10157-013-0782-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 321: 1-7, 1989.","DOI":"10.1056\/NEJM198907063210101"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Linn\u00e9r A, Darenberg J, Sj\u00f6lin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59: 851-857, 2014.","DOI":"10.1093\/cid\/ciu449"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Stevens DL. The flesh-eating bacterium: what&apos;s next? J Infect Dis 179 (Suppl 2): S366-S374, 1999.","DOI":"10.1086\/513851"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Vartian C, Lerner PI, Shlaes DM, Gopalakrishna KV. Infections due to Lancefield group G streptococci. Medicine (Baltimore) 64: 75-88, 1985.","DOI":"10.1097\/00005792-198503000-00001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takahashi T, Sunaoshi K, Sunakawa K, Fujishima S, Watanabe H, Ubukata K. Clinical aspects of invasive infections with <i>Streptococcus dysgalactiae<\/i> ssp. <i>equisimilis<\/i> in Japan: differences with respect to <i>Streptococcus pyogenes<\/i> and <i>Streptococcus agalactiae<\/i> infections. Clin Microbiol Infect 16: 1097-1103, 2010.","DOI":"10.1111\/j.1469-0691.2009.03047.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Broyles LN, Van Beneden C, Beall B, et al. Population-based study of invasive disease due to \u03b2-hemolytic streptococci of groups other than A and B. Clin Infect Dis 48: 706-712, 2009.","DOI":"10.1086\/597035"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ergin A, Ercis S, Has\u00e7elik G. In vitro susceptibility, tolerance and MLS resistance phenotypes of Group C and Group G streptococci isolated in Turkey between 1995 and 2002. Int J Antimicrob Agents 22: 160-163, 2003.","DOI":"10.1016\/S0924-8579(03)00081-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ip M, Lyon DJ, Leung T, Cheng AF. Macrolide resistance and distribution of <i>erm<\/i> and <i>mef<\/i> genes among beta-haemolytic streptococci in Hong Kong. Eur J Clin Microbiol Infect Dis 21: 238-240, 2002.","DOI":"10.1007\/s10096-001-0686-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Brown DF, Hope R, Livermore DM, et al. Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 62 (Suppl 2): ii75-ii85, 2008.","DOI":"10.1093\/jac\/dkn354"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sunaoshi K, Murayama SY, Adachi K, et al. Molecular <i>emm<\/i> genotyping and antibiotic susceptibility of <i>Streptococcus dysgalactiae<\/i> subsp. <i>equisimilis<\/i> isolated from invasive and non-invasive infections. J Med Microbiol 59: 82-88, 2010.","DOI":"10.1099\/jmm.0.013201-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Biedenbach DJ, Toleman MA, Walsh TR, Jones RN. Characterization of fluoroquinolone-resistant \u03b2-hemolytic <i>Streptococcus<\/i> spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant <i>Streptococcus dysgalactiae<\/i> subspecies <i>equisimilis<\/i>: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn Microbiol Infect Dis 55: 119-127, 2006.","DOI":"10.1016\/j.diagmicrobio.2005.12.006"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Rantala S. <i>Streptococcus dysgalactiae<\/i> subsp. <i>equisimilis<\/i> bacteremia: an emerging infection. Eur J Clin Microbiol Infect Dis 33: 1303-1310, 2014.","DOI":"10.1007\/s10096-014-2092-0"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/1\/62_9467-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T03:25:17Z","timestamp":1673061917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/1\/62_9467-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9467-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"9467-22"}}